American Century Companies’s Abeona Therapeutics ABEO Stock Holding History
Bought
Maintained
Sold
Other funds holding ABEO
NCM
CCC
ACM
OIA
AIC
KCM
American Century Companies's ABEO Position: Q2 2026 in Review
American Century Companies increased its Abeona Therapeutics (ABEO) stake by 265% in Q2 2026, buying an estimated $185K and bringing the position to 46,415 shares worth $287K. The position accounts for ﹤0.01% of the portfolio, ranked #2711.
American Century Companies first reported a position in ABEO in Q1 2026 and has held it in 2 quarters since. 126 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.
- American Century Companies held 46,415 shares of Abeona Therapeutics worth $287K as of Q2 2026.
- American Century Companies bought 33,697 Abeona Therapeutics shares in Q2 2026, an estimated $185K.
- Abeona Therapeutics made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2711 holding.
- American Century Companies first reported a position in Abeona Therapeutics in Q1 2026 and has held it in 2 quarters since.
- 126 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.